Ganga Pharma.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE615T01017
NSEID:
BSEID: 539680
View on BSE

INR

12.50

0.00 (0.00%)

BSENSE

Sep 18, 03:30 PM

BSE+NSE Vol: 16.0 k

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Beryl Drugs

Brawn Biotech

Vivanza Biosci.

Decipher Labs

Solara Active PP

Ortin Global

Dipna Pharmachem

Starsource Multi

Genomic Valley

Ganga Pharma.

Fabino Enter

Why is Ganga Pharmaceuticals Ltd ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.60%

EBIT Growth (5y)

0.40%

EBIT to Interest (avg)

-0.04

Debt to EBITDA (avg)

1.22

Net Debt to Equity (avg)

0.12

Sales to Capital Employed (avg)

0.38

Tax Ratio

23.08%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

2.31%

ROE (avg)

0.99%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.89

EV to EBIT

-8.42

EV to EBITDA

8.42

EV to Capital Employed

0.90

EV to Sales

2.98

PEG Ratio

Dividend Yield

ROCE (Latest)

-0.11%

ROE (Latest)

1.20%

Loading Valuation Snapshot...

Technicals

Technical key factors

No Data found

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Loading Valuation Snapshot...